B87.81
Genitourinary myiasis
Clinical Classification Guidelines
Medical Intelligence & Overview
Genitourinary myiasis is a rare parasitic infection involving the invasion of the genitourinary system by fly larvae, known as maggots. This condition can affect both men and women, typically resulting from exposure to environments contaminated with fly eggs. The presence of larvae within the urogenital organs can lead to discomfort, infection, and other health complications. Recognizing this condition is crucial for effective treatment and management.
Causes & Symptoms
Clinical Causes: Exposure to environments with decaying organic matter at places like farms, garbage sites, or unsanitary conditions Poor personal hygiene, especially in settings lacking adequate sanitation facilities Contact with contaminated water or soil carrying fly eggs Inadvertent transfer of eggs or larvae through contaminated clothing or bedding Pre-existing open wounds or lesions in the genitourinary area that attract flies
Key Symptoms: Pain or discomfort in the genital or urinary regions Visible maggots or larvae in urine, genital area, or during urination Swelling, redness, or inflammation of the affected area Unusual discharge, often foul-smelling Bleeding or ulceration in the genitourinary tissues Fever or signs of secondary infection in severe cases Itching or irritation in the genital area
Diagnostic & Treatment
Diagnosis Path: The diagnosis of genitourinary myiasis is typically made through clinical examination, where larvae may be directly observed in the affected areas. Urinalysis or tissue sampling can help confirm the presence of larvae. Imaging studies are rarely needed but may assist in identifying deep-seated infections. A detailed patient history focusing on environmental exposure is also essential for diagnosis.
Treatment Protocols: Managing genitourinary myiasis involves the removal of all identifiable larvae from the affected tissues, often performed manually under local or general anesthesia. Antiparasitic medications, such as ivermectin, may be prescribed to eliminate remaining larvae and prevent recurrence. Proper wound care and hygiene practices are crucial to prevent further infestation and secondary infections. In some cases, antibiotics might be required to treat or prevent bacterial infections associated with tissue damage.
Clinical Advice & FAQs
Billing Guidance
Is B87.81 a billable ICD-10 code?
Yes, B87.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B87.81?
Clinical documentation must specify the nature of Genitourinary myiasis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
